413 related articles for article (PubMed ID: 24965469)
1. Impaired Nef function is associated with early control of HIV-1 viremia.
Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA
J Virol; 2014 Sep; 88(17):10200-13. PubMed ID: 24965469
[TBL] [Abstract][Full Text] [Related]
2. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of multiple Nef functions in HIV-1 elite controllers.
Mwimanzi P; Markle TJ; Martin E; Ogata Y; Kuang XT; Tokunaga M; Mahiti M; Pereyra F; Miura T; Walker BD; Brumme ZL; Brockman MA; Ueno T
Retrovirology; 2013 Jan; 10():1. PubMed ID: 23289738
[TBL] [Abstract][Full Text] [Related]
4. Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.
Jin SW; Alsahafi N; Kuang XT; Swann SA; Toyoda M; Göttlinger H; Walker BD; Ueno T; Finzi A; Brumme ZL; Brockman MA
Cell Rep; 2019 Nov; 29(6):1449-1457.e5. PubMed ID: 31693887
[TBL] [Abstract][Full Text] [Related]
5. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
[TBL] [Abstract][Full Text] [Related]
6. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.
Mann JK; Byakwaga H; Kuang XT; Le AQ; Brumme CJ; Mwimanzi P; Omarjee S; Martin E; Lee GQ; Baraki B; Danroth R; McCloskey R; Muzoora C; Bangsberg DR; Hunt PW; Goulder PJ; Walker BD; Harrigan PR; Martin JN; Ndung'u T; Brockman MA; Brumme ZL
Retrovirology; 2013 Sep; 10():100. PubMed ID: 24041011
[TBL] [Abstract][Full Text] [Related]
7. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
[TBL] [Abstract][Full Text] [Related]
9. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
[TBL] [Abstract][Full Text] [Related]
10. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
11. Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.
Specht A; Telenti A; Martinez R; Fellay J; Bailes E; Evans DT; Carrington M; Hahn BH; Goldstein DB; Kirchhoff F
J Virol; 2010 Jul; 84(14):7300-11. PubMed ID: 20463068
[TBL] [Abstract][Full Text] [Related]
12. HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers.
Miura T; Brumme CJ; Brockman MA; Brumme ZL; Pereyra F; Block BL; Trocha A; John M; Mallal S; Harrigan PR; Walker BD
J Virol; 2009 Apr; 83(7):3407-12. PubMed ID: 19153230
[TBL] [Abstract][Full Text] [Related]
13. Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.
Toyoda M; Kamori D; Tan TS; Goebuchi K; Ohashi J; Carlson J; Kawana-Tachikawa A; Gatanaga H; Oka S; Pizzato M; Ueno T
Sci Rep; 2020 Nov; 10(1):19416. PubMed ID: 33173092
[TBL] [Abstract][Full Text] [Related]
14. Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences.
Mahiti M; Toyoda M; Jia X; Kuang XT; Mwimanzi F; Mwimanzi P; Walker BD; Xiong Y; Brumme ZL; Brockman MA; Ueno T
mBio; 2016 Jan; 7(1):e01516-15. PubMed ID: 26787826
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
[TBL] [Abstract][Full Text] [Related]
17. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
[TBL] [Abstract][Full Text] [Related]
18. An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.
Mumby MJ; Johnson AL; Trothen SM; Edgar CR; Gibson R; Stathopulos PB; Arts EJ; Dikeakos JD
J Virol; 2021 Jul; 95(16):e0058821. PubMed ID: 34037423
[TBL] [Abstract][Full Text] [Related]
19. Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.
Lewis MJ; Lee P; Ng HL; Yang OO
J Virol; 2012 Jul; 86(13):7126-35. PubMed ID: 22553319
[TBL] [Abstract][Full Text] [Related]
20. An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles.
Mwimanzi F; Ngare I; Toyoda M; Mori M; Mann J; Ndung'u T; Goulder P; Ueno T
AIDS; 2020 Jul; 34(9):1325-1330. PubMed ID: 32590431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
